Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | -4,283 | N/A | N/A |
| Depreciation Amortization | 196 | N/A | N/A |
| Accounts receivable | -416 | N/A | N/A |
| Accounts payable and accrued liabilities | 150 | N/A | N/A |
| Other Working Capital | -323 | N/A | N/A |
| Other Operating Activity | 279 | 0 | 0 |
| Operating Cash Flow | $-4,397 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -731 | N/A | N/A |
| Other Investing Activity | -49 | 0 | 0 |
| Investing Cash Flow | $-780 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 4,000 | N/A | N/A |
| Financing Cash Flow | $4,000 | $N/A | $N/A |
| Beginning Cash Position | 1,349 | N/A | N/A |
| End Cash Position | 172 | N/A | N/A |
| Net Cash Flow | $-1,177 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -4,397 | N/A | N/A |
| Capital Expenditure | -731 | N/A | N/A |
| Free Cash Flow | -5,128 | 0 | 0 |